Triage method for endometrial biopsy in postmenopausal women: a multicenter retrospective cohort study

Menopause. 2023 Dec 1;30(12):1206-1212. doi: 10.1097/GME.0000000000002271. Epub 2023 Oct 31.

Abstract

Objective: To identify the optimal triage procedure for endometrial biopsies in postmenopausal women.

Methods: The clinical information of 470 postmenopausal women with endometrial biopsy results and postmenopausal bleeding (PMB) and/or transvaginal ultrasonography (TVU) abnormalities were collected at the gynecology departments of four general hospitals from March 2021 to March 2022. In the validation cohort, 112 women with TVU abnormalities who underwent endometrial biopsy at Xiangya hospital between May 2022 and May 2023 were enrolled. The endpoint was the final diagnosis based on hysteroscopy reports and biopsy pathology results. The sensitivity, specificity, positive predictive value, and negative predictive value were compared among the three triage methods. A nomogram prediction model was developed and validated.

Results: Referring women with TVU abnormalities for endometrial biopsy identified 100% malignant/premalignant lesions despite low specificity (19.7%). Among women with measurable endometrial thickness (ET), we suggest that the ET cutoff value for biopsy referral should be ≥4 mm. The PMB (odds ratio [OR], 3.241; 95% confidence interval [CI], 1.073-9.789), diabetes (OR, 10.915; 95% CI, 3.389-35.156), and endometrial thickness (OR, 1.277; 95% CI, 1.156-1.409) were independent predictive factors for endometrial (pre)malignancy. A nomogram prediction model was constructed (area under curve [AUC] = 0.802, 95% CI: 0.715 to 0.889). The ideal cutoff point was 22.5, with a sensitivity of 100.0% and a specificity of 15.7%. The external validation achieved an AUC of 0.798 (95% CI, 0.685-0.911).

Conclusions: It was possible to refer all postmenopausal women with TVU abnormity (ET ≥ 4 mm or other abnormal findings) for endometrial biopsy. Among women with TVU abnormalities, a nomogram was constructed, and a score greater than 22.5 suggested the need for referral for endometrial biopsy, while a score less than 22.5 suggested that regular follow-up was required, further improving the triage procedure.

Publication types

  • Multicenter Study

MeSH terms

  • Biopsy
  • Endometrial Neoplasms* / pathology
  • Endometrium / diagnostic imaging
  • Endometrium / pathology
  • Female
  • Humans
  • Hysteroscopy
  • Postmenopause*
  • Pregnancy
  • Retrospective Studies
  • Sensitivity and Specificity
  • Triage
  • Ultrasonography
  • Uterine Hemorrhage / diagnostic imaging